(Q71102203)

English

Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials

scientific article published on 01 June 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Buzdar AU

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Smith R

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Vogel C

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Bonomi P

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Keller AM

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Favis G

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Mulagha M

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Cooper J

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

0 references

publication date

1 June 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

77

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

2503-2513

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Current status of endocrine treatment of carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Aromatase inhibition by delta 1-testolactone does not relieve the gonadotropin-induced late steroidogenic block in normal men

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

First generation aromatase inhibitors--aminoglutethimide and testololactone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Specificity of Low Dose Fadrozole Hydrochloride (CGS 16949A) as an Aromatase Inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960615%2977%3A12%3C2503%3A%3AAID-CNCR13%3E3.0.CO%3B2-W

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19960615)77:12<2503::AID-CNCR13>3.0.CO;2-W

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640699%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71102203&oldid=1831724837"